OpenVSafe by OpenVAERS
Search V-safe

HGU-21072-10598

3 vaccinations 4 coded responses 33 check-ins 4 free-text entries 6 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
435 / OH
Registered
2020-12-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-15
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-17
    Registered in v-safe
  3. 2020-12-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-05
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blindness, Hyperhidrosis, Medical counselling, Paraesthesia, Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Syncopal episode, complete loss of vision in both eyes (blindness), tingly hands and feet, sweating · Healthcare visit (other): I work at a hospital. I have been checking in with our vaccination team and received direction from our CMO and ED Director.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-06
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    2 call case(s)
  12. 2021-01-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-07
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-01-28
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-02
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-09
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-15
  24. 2021-02-16
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-16
  26. 2021-02-16
    Call successful
    Participant prefers to complete VAERS report online
  27. 2021-02-16
    Call successful
    Participant prefers to complete VAERS report online
  28. 2021-02-16
    Call successful
    Participant prefers to complete VAERS report online
  29. 2021-04-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-07-06
    Survey response — 6 months, dose 2
    MedDRA: Anxiety, Depression, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: High anxiety and depression · Healthcare visit (other): Weekly psychologist appointments
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  31. 2021-07-06
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  32. 2021-07-08
  33. 2021-09-28
    Dose 3 — Pfizer-BioNTech
  34. 2021-09-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness
    Adult check-in
  35. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  36. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  37. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-10-05
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  39. 2021-10-13
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-10-19
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-10-28
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  42. 2021-11-02
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-11-09
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  44. 2021-12-28
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-03-29
    Survey response — 6 months, dose 3
    MedDRA: Depression, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Depression · Healthcare visit (other): Primary care physician
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-03-29
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  47. 2022-03-30
  48. 2022-09-28
    Survey response — 12 months, dose 3
    MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-09-28
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  50. 2022-09-29
    Call successful
    Participant prefers to complete VAERS report online
  51. 2022-09-29
    Call successful
    Participant prefers to complete VAERS report online
  52. 2022-09-29
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-15Pfizer-BioNTech
22021-01-05Pfizer-BioNTech
32021-09-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-06 Successful
2021-02-16
Participant prefers to complete VAERS report online
2021-01-06 Successful
2021-02-16
Participant prefers to complete VAERS report online
2021-01-07 Successful
2021-02-16
Participant prefers to complete VAERS report online
2021-07-06 Successful
2022-09-29
Participant prefers to complete VAERS report online
2022-03-29 Successful
2022-09-29
Participant prefers to complete VAERS report online
2022-09-28 Successful
2022-09-29
Participant prefers to complete VAERS report online

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-06

Systemic reaction (other): Syncopal episode, complete loss of vision in both eyes (blindness), tingly hands and feet, sweating
Healthcare visit (other): I work at a hospital. I have been checking in with our vaccination team and received direction from our CMO and ED Director.

Release 9 — 6 months, dose 2

2021-07-06

Symptoms: High anxiety and depression
Healthcare visit (other): Weekly psychologist appointments

Release 11 — 6 months, dose 3

2022-03-29

Symptoms: Depression
Healthcare visit (other): Primary care physician

Release 12 — 12 months, dose 3

2022-09-28

Symptoms: Miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
HCVOOffice visit ✓ ✓ ✓
SDAbortion spontaneous · · ✓
SDAnxiety ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SROBlindness ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release